BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 9218847)

  • 1. Complement coating of erythrocytes is reduced following their interaction with neutrophils in vitro without loss of complement receptor 1 (CR1).
    Imrie HJ; Jones DR
    Clin Exp Immunol; 1997 Jul; 109(1):217-22. PubMed ID: 9218847
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Erythrocyte enhancement of C3b-mediated phagocytosis by human neutrophils in vitro: a combined effect of the erythrocyte complement receptors CR1 and erythrocyte scavengers to reactive oxygen metabolites (ROM).
    Forslid J; Hed J; Stendahl O
    Immunology; 1985 May; 55(1):97-103. PubMed ID: 3158597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Staphylococcal protein Ecb impairs complement receptor-1 mediated recognition of opsonized bacteria.
    Amdahl H; Haapasalo K; Tan L; Meri T; Kuusela PI; van Strijp JA; Rooijakkers S; Jokiranta TS
    PLoS One; 2017; 12(3):e0172675. PubMed ID: 28273167
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of complement receptor type 1 (CR1, CD35) in determining the cellular distribution of opsonized immune complexes between whole blood cells: kinetic analysis of the buffering capacity of erythrocytes.
    Nielsen CH; Matthiesen SH; Lyng I; Leslie RG
    Immunology; 1997 Jan; 90(1):129-37. PubMed ID: 9038723
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Processing of C3b-opsonized immune complexes bound to non-complement receptor 1 (CR1) sites on red cells: phagocytosis, transfer, and associations with CR1.
    Craig ML; Waitumbi JN; Taylor RP
    J Immunol; 2005 Mar; 174(5):3059-66. PubMed ID: 15728520
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The binding of immune complexes by the erythrocyte complement receptor 1 (CR1).
    Pascual M; Schifferli JA
    Immunopharmacology; 1992; 24(2):101-6. PubMed ID: 1473961
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune complex binding efficiency of erythrocyte complement receptor 1 (CR1).
    Madi N; Paccaud JP; Steiger G; Schifferli JA
    Clin Exp Immunol; 1991 Apr; 84(1):9-15. PubMed ID: 1826650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Quantitative analysis of C4Ab and C4Bb binding to the C3b/C4b receptor (CR1, CD35).
    Reilly BD; Mold C
    Clin Exp Immunol; 1997 Nov; 110(2):310-6. PubMed ID: 9367418
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune complex-like moieties in immunoglobulin for intravenous use (i.v.Ig) bind complement and enhance phagocytosis of human erythrocytes.
    Shoham-Kessary H; Naot Y; Gershon H
    Clin Exp Immunol; 1998 Jul; 113(1):77-84. PubMed ID: 9697987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of antibody isotype and antigenic epitope density on the complement-fixing activity of immune complexes: a systematic study using chimaeric anti-NIP antibodies with human Fc regions.
    Lucisano Valim YM; Lachmann PJ
    Clin Exp Immunol; 1991 Apr; 84(1):1-8. PubMed ID: 1707767
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Key role of the number of complement receptor 1 on erythrocytes for binding of Escherichia coli to erythrocytes and for leukocyte phagocytosis and oxidative burst in human whole blood.
    Brekke OL; Christiansen D; Kisserli A; Fure H; Dahl JA; Donvito B; Reveil B; Ludviksen JK; Tabary T; Mollnes TE; Cohen JHM
    Mol Immunol; 2019 Oct; 114():139-148. PubMed ID: 31352230
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Erythrocyte CR1 receptor: binding and transport of immune complexes in the blood circulation].
    Pascual M; Schifferli JA
    Schweiz Med Wochenschr; 1993 Jan; 123(3):39-43. PubMed ID: 8426946
    [TBL] [Abstract][Full Text] [Related]  

  • 13. C1q and C4b bind simultaneously to CR1 and additively support erythrocyte adhesion.
    Tas SW; Klickstein LB; Barbashov SF; Nicholson-Weller A
    J Immunol; 1999 Nov; 163(9):5056-63. PubMed ID: 10528211
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Defective complement receptors (CR1 and CR3) on erythrocytes and leukocytes of factor I (C3b-inactivator) deficient patients.
    Porteu F; Fischer A; Descamps-Latscha B; Halbwachs-Mecarelli L
    Clin Exp Immunol; 1986 Nov; 66(2):463-71. PubMed ID: 2949901
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heteropolymer-mediated clearance of immune complexes via erythrocyte CR1: mechanisms and applications.
    Lindorfer MA; Hahn CS; Foley PL; Taylor RP
    Immunol Rev; 2001 Oct; 183():10-24. PubMed ID: 11782244
    [TBL] [Abstract][Full Text] [Related]  

  • 16. How are immune complexes bound to the primate erythrocyte complement receptor transferred to acceptor phagocytic cells?
    Nardin A; Lindorfer MA; Taylor RP
    Mol Immunol; 1999; 36(13-14):827-35. PubMed ID: 10698336
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complement-opsonized IgG antibody/dsDNA immune complexes bind to CR1 clusters on isolated human erythrocytes.
    Taylor RP; Pocanic F; Reist C; Wright EL
    Clin Immunol Immunopathol; 1991 Nov; 61(2 Pt 1):143-60. PubMed ID: 1833104
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A soluble recombinant multimeric anti-Rh(D) single-chain Fv/CR1 molecule restores the immune complex binding ability of CR1-deficient erythrocytes.
    Oudin S; Libyh MT; Goossens D; Dervillez X; Philbert F; Réveil B; Bougy F; Tabary T; Rouger P; Klatzmann D; Cohen JH
    J Immunol; 2000 Feb; 164(3):1505-13. PubMed ID: 10640768
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immune complexes and erythrocyte CR1 (complement receptor type 1): effect of CR1 numbers on binding and release reactions.
    Ng YC; Schifferli JA; Walport MJ
    Clin Exp Immunol; 1988 Mar; 71(3):481-5. PubMed ID: 2968204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Another function of erythrocytes: transport of circulating immune complexes.
    Pascual M; Schifferli JA
    Infusionsther Transfusionsmed; 1995 Oct; 22(5):310-5. PubMed ID: 8924746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.